What is the current valuation of the market as of 2024?

The market was valued at 10.63 USD Billion in 2024. Read More

What is the projected market valuation for the market in 2035?

The market is projected to reach a valuation of 34.69 USD Billion by 2035. Read More

What is the expected CAGR for the market during the forecast period 2025 - 2035?

The expected CAGR for the Nuclear Medicine Market during the forecast period 2025 - 2035 is 11.35%. Read More

Which companies are considered key players in the Nuclear Medicine Market?

Key players in the Nuclear Medicine Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems. Read More

How does the Diagnostic Imaging segment perform in terms of market valuation?

The Diagnostic Imaging segment was valued at 3.5 USD Billion in 2024 and is projected to reach 12.0 USD Billion by 2035. Read More

What is the market valuation for the Therapeutic Applications segment?

The Therapeutic Applications segment was valued at 2.5 USD Billion in 2024 and is expected to grow to 8.5 USD Billion by 2035. Read More

Which radioisotope types are significant in the Nuclear Medicine Market?

Significant radioisotope types include Technetium-99m, Iodine-131, Fluorine-18, and Yttrium-90. Read More

What is the projected growth for the Pharmaceutical Companies segment in the Nuclear Medicine Market?

The Pharmaceutical Companies segment was valued at 4.25 USD Billion in 2024 and is anticipated to reach 13.04 USD Billion by 2035. Read More

Nuclear Medicine Market

Q: What are the main application segments of the Nuclear Medicine Market?

The main application segments include Diagnostic Imaging, Therapeutic Applications, Radiopharmaceutical Production, and Research Applications. Read More

Q: What procedures are included in the Nuclear Medicine Market analysis?

The procedures analyzed include Positron Emission Tomography, Single-Photon Emission Computed Tomography, Radiotherapy, and Brachytherapy. Read More

ID: MRFR/HC/5211-CR

200 Pages

Rahul Gotadki

Last Updated: May 13, 2026

Nuclear Medicine Market Research Report: Size, Share, Trend Analysis By Applications (Diagnostic Imaging, Therapeutic Applications, Radiopharmaceutical Production, Research Applications), By Radioisotope Type (Technetium-99m, Iodine-131, Fluorine-18, Yttrium-90), By End Users (Hospitals, Diagnostic Imaging Centers, Academic Research Institutions, Pharmaceutical Companies), By Procedure (Positron Emission Tomography, Single-Photon Emission Computed Tomography, Radiotherapy, Brachytherapy) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Nuclear Medicine Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)11.35%

2024 Market Size$ 10.63 Billion

2025 Market Size$ 11.84 Billion

2035 Market Size$ 34.69 Billion

Key Players

Companies such as GE Healthcare

Siemens Healthineers

Philips Healthcare

Canon Medical Systems

Elekta

Bayer AG

Trends

Technological Advancements
Personalized Medicine
Sustainability Initiatives

Opportunities

Aging Population
Increasing Incidence of Cancer
Rising Awareness of Nuclear Medicine

Summary Table of Contents Segmentation Methodology Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Billion) | |
  1. 4.1.1 Diagnostic Imaging | |
  2. 4.1.2 Therapeutic Applications | |
  3. 4.1.3 Radiopharmaceutical Production | |
  4. 4.1.4 Research Applications |
2. 4.2 Healthcare, BY Radioisotope Type (USD Billion) | |
  1. 4.2.1 Technetium-99m | |
  2. 4.2.2 Iodine-131 | |
  3. 4.2.3 Fluorine-18 | |
  4. 4.2.4 Yttrium-90 |
3. 4.3 Healthcare, BY End User (USD Billion) | |
  1. 4.3.1 Hospitals | |
  2. 4.3.2 Diagnostic Imaging Centers | |
  3. 4.3.3 Academic Research Institutions | |
  4. 4.3.4 Pharmaceutical Companies |
4. 4.4 Healthcare, BY Procedure (USD Billion) | |
  1. 4.4.1 Positron Emission Tomography | |
  2. 4.4.2 Single-Photon Emission Computed Tomography | |
  3. 4.4.3 Radiotherapy | |
  4. 4.4.4 Brachytherapy |
5. 4.5 Healthcare, BY Region (USD Billion) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 GE Healthcare (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Siemens Healthineers (DE) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Philips Healthcare (NL) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Canon Medical Systems (JP) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Elekta (SE) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Bayer AG (DE) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Bracco Imaging (IT) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Lantheus Medical Imaging (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 NorthStar Medical Radioisotopes (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY APPLICATION |
7. 6.4 US MARKET ANALYSIS BY RADIOISOTOPE TYPE |
8. 6.5 US MARKET ANALYSIS BY END USER |
9. 6.6 US MARKET ANALYSIS BY PROCEDURE |
10. 6.7 CANADA MARKET ANALYSIS BY APPLICATION |
11. 6.8 CANADA MARKET ANALYSIS BY RADIOISOTOPE TYPE |
12. 6.9 CANADA MARKET ANALYSIS BY END USER |
13. 6.10 CANADA MARKET ANALYSIS BY PROCEDURE |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION |
16. 6.13 GERMANY MARKET ANALYSIS BY RADIOISOTOPE TYPE |
17. 6.14 GERMANY MARKET ANALYSIS BY END USER |
18. 6.15 GERMANY MARKET ANALYSIS BY PROCEDURE |
19. 6.16 UK MARKET ANALYSIS BY APPLICATION |
20. 6.17 UK MARKET ANALYSIS BY RADIOISOTOPE TYPE |
21. 6.18 UK MARKET ANALYSIS BY END USER |
22. 6.19 UK MARKET ANALYSIS BY PROCEDURE |
23. 6.20 FRANCE MARKET ANALYSIS BY APPLICATION |
24. 6.21 FRANCE MARKET ANALYSIS BY RADIOISOTOPE TYPE |
25. 6.22 FRANCE MARKET ANALYSIS BY END USER |
26. 6.23 FRANCE MARKET ANALYSIS BY PROCEDURE |
27. 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION |
28. 6.25 RUSSIA MARKET ANALYSIS BY RADIOISOTOPE TYPE |
29. 6.26 RUSSIA MARKET ANALYSIS BY END USER |
30. 6.27 RUSSIA MARKET ANALYSIS BY PROCEDURE |
31. 6.28 ITALY MARKET ANALYSIS BY APPLICATION |
32. 6.29 ITALY MARKET ANALYSIS BY RADIOISOTOPE TYPE |
33. 6.30 ITALY MARKET ANALYSIS BY END USER |
34. 6.31 ITALY MARKET ANALYSIS BY PROCEDURE |
35. 6.32 SPAIN MARKET ANALYSIS BY APPLICATION |
36. 6.33 SPAIN MARKET ANALYSIS BY RADIOISOTOPE TYPE |
37. 6.34 SPAIN MARKET ANALYSIS BY END USER |
38. 6.35 SPAIN MARKET ANALYSIS BY PROCEDURE |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY RADIOISOTOPE TYPE |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USER |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY APPLICATION |
45. 6.42 CHINA MARKET ANALYSIS BY RADIOISOTOPE TYPE |
46. 6.43 CHINA MARKET ANALYSIS BY END USER |
47. 6.44 CHINA MARKET ANALYSIS BY PROCEDURE |
48. 6.45 INDIA MARKET ANALYSIS BY APPLICATION |
49. 6.46 INDIA MARKET ANALYSIS BY RADIOISOTOPE TYPE |
50. 6.47 INDIA MARKET ANALYSIS BY END USER |
51. 6.48 INDIA MARKET ANALYSIS BY PROCEDURE |
52. 6.49 JAPAN MARKET ANALYSIS BY APPLICATION |
53. 6.50 JAPAN MARKET ANALYSIS BY RADIOISOTOPE TYPE |
54. 6.51 JAPAN MARKET ANALYSIS BY END USER |
55. 6.52 JAPAN MARKET ANALYSIS BY PROCEDURE |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY RADIOISOTOPE TYPE |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USER |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE |
60. 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION |
61. 6.58 MALAYSIA MARKET ANALYSIS BY RADIOISOTOPE TYPE |
62. 6.59 MALAYSIA MARKET ANALYSIS BY END USER |
63. 6.60 MALAYSIA MARKET ANALYSIS BY PROCEDURE |
64. 6.61 THAILAND MARKET ANALYSIS BY APPLICATION |
65. 6.62 THAILAND MARKET ANALYSIS BY RADIOISOTOPE TYPE |
66. 6.63 THAILAND MARKET ANALYSIS BY END USER |
67. 6.64 THAILAND MARKET ANALYSIS BY PROCEDURE |
68. 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION |
69. 6.66 INDONESIA MARKET ANALYSIS BY RADIOISOTOPE TYPE |
70. 6.67 INDONESIA MARKET ANALYSIS BY END USER |
71. 6.68 INDONESIA MARKET ANALYSIS BY PROCEDURE |
72. 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION |
73. 6.70 REST OF APAC MARKET ANALYSIS BY RADIOISOTOPE TYPE |
74. 6.71 REST OF APAC MARKET ANALYSIS BY END USER |
75. 6.72 REST OF APAC MARKET ANALYSIS BY PROCEDURE |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION |
78. 6.75 BRAZIL MARKET ANALYSIS BY RADIOISOTOPE TYPE |
79. 6.76 BRAZIL MARKET ANALYSIS BY END USER |
80. 6.77 BRAZIL MARKET ANALYSIS BY PROCEDURE |
81. 6.78 MEXICO MARKET ANALYSIS BY APPLICATION |
82. 6.79 MEXICO MARKET ANALYSIS BY RADIOISOTOPE TYPE |
83. 6.80 MEXICO MARKET ANALYSIS BY END USER |
84. 6.81 MEXICO MARKET ANALYSIS BY PROCEDURE |
85. 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION |
86. 6.83 ARGENTINA MARKET ANALYSIS BY RADIOISOTOPE TYPE |
87. 6.84 ARGENTINA MARKET ANALYSIS BY END USER |
88. 6.85 ARGENTINA MARKET ANALYSIS BY PROCEDURE |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY RADIOISOTOPE TYPE |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY RADIOISOTOPE TYPE |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY RADIOISOTOPE TYPE |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE |
102. 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION |
103. 6.100 REST OF MEA MARKET ANALYSIS BY RADIOISOTOPE TYPE |
104. 6.101 REST OF MEA MARKET ANALYSIS BY END USER |
105. 6.102 REST OF MEA MARKET ANALYSIS BY PROCEDURE |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
114. 6.111 HEALTHCARE, BY RADIOISOTOPE TYPE, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY RADIOISOTOPE TYPE, 2024 TO 2035 (USD Billion) |
116. 6.113 HEALTHCARE, BY END USER, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
118. 6.115 HEALTHCARE, BY PROCEDURE, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY PROCEDURE, 2024 TO 2035 (USD Billion) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY PROCEDURE, 2025-2035 (USD Billion) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY PROCEDURE, 2025-2035 (USD Billion) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY PROCEDURE, 2025-2035 (USD Billion) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY PROCEDURE, 2025-2035 (USD Billion) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY PROCEDURE, 2025-2035 (USD Billion) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY PROCEDURE, 2025-2035 (USD Billion) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY PROCEDURE, 2025-2035 (USD Billion) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY PROCEDURE, 2025-2035 (USD Billion) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY PROCEDURE, 2025-2035 (USD Billion) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY PROCEDURE, 2025-2035 (USD Billion) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY PROCEDURE, 2025-2035 (USD Billion) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY PROCEDURE, 2025-2035 (USD Billion) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY PROCEDURE, 2025-2035 (USD Billion) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY PROCEDURE, 2025-2035 (USD Billion) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY PROCEDURE, 2025-2035 (USD Billion) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY PROCEDURE, 2025-2035 (USD Billion) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY PROCEDURE, 2025-2035 (USD Billion) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY PROCEDURE, 2025-2035 (USD Billion) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY PROCEDURE, 2025-2035 (USD Billion) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY PROCEDURE, 2025-2035 (USD Billion) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY PROCEDURE, 2025-2035 (USD Billion) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY PROCEDURE, 2025-2035 (USD Billion) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY PROCEDURE, 2025-2035 (USD Billion) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY PROCEDURE, 2025-2035 (USD Billion) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY PROCEDURE, 2025-2035 (USD Billion) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY PROCEDURE, 2025-2035 (USD Billion) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY PROCEDURE, 2025-2035 (USD Billion) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY PROCEDURE, 2025-2035 (USD Billion) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY RADIOISOTOPE TYPE, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY PROCEDURE, 2025-2035 (USD Billion) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Nuclear Medicine Market Segmentation

Nuclear Medicine Market By Application (USD Billion, 2025-2035)

Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications

Nuclear Medicine Market By Radioisotope Type (USD Billion, 2025-2035)

Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90

Nuclear Medicine Market By End User (USD Billion, 2025-2035)

Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Nuclear Medicine Market Companies

Nuclear Medicine Market By Procedure (USD Billion, 2025-2035)

Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”